GO
Loading...

Eli Lilly and Co

More

  • Final Glance: Pharmaceuticals companies Thursday, 30 Oct 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 35 or. 5 percent, to $70.06. Bristol-Myers Squibb Co. rose $4.82 or 8.9 percent, to $58.98. Hospira rose $2.17 or 4.2 percent, to $54.24.

  • Midday Glance: Pharmaceuticals companies Thursday, 30 Oct 2014 | 1:17 PM ET

    Baxter International Inc. fell$. 79 or 1.1 percent, to $69.62. Bristol-Myers Squibb Co. rose $4.22 or 7.8 percent, to $58.38. Hospira rose $1.34 or 2.6 percent, to $53.41.

  • Early Glance: Pharmaceuticals companies Thursday, 30 Oct 2014 | 11:28 AM ET

    Baxter International Inc. fell$. 49 or. 7 percent, to $69.92. Bristol-Myers Squibb Co. rose $2.14 or 4.0 percent, to $56.30. Hospira fell$. 25 or. 5 percent, to $51.82.

  • Final Glance: Pharmaceuticals companies Wednesday, 29 Oct 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 09 or. 1 percent, to $70.41. Bristol-Myers Squibb Co. fell$. 04 or. 1 percent, to $54.16. Hospira fell$. 23 or. 4 percent, to $52.07.

  • Midday Glance: Pharmaceuticals companies Wednesday, 29 Oct 2014 | 1:41 PM ET

    Baxter International Inc. rose$. 01 or percent, to $70.33. Bristol-Myers Squibb Co. fell$. 23 or. 4 percent, to $53.97. Hospira fell$. 16 or. 3 percent, to $52.14.

  • Early Glance: Pharmaceuticals companies Wednesday, 29 Oct 2014 | 10:53 AM ET

    Baxter International Inc. rose$. 16 or. 2 percent, to $70.48. Bristol-Myers Squibb Co. fell$. 17 or. 3 percent, to $54.03. Hospira rose$. 18 or. 3 percent, to $52.48.

  • Boehringer and Lilly will continue to jointly develop and market these drugs in 17 countries, including the United States, they said in a statement on Wednesday. A new insulin glargine product, which is approved in Europe, has won tentative approval in the United States. Sanofi SA said on Tuesday that growth in sales of its diabetes drugs would stall next year due...

  • Lilly, Boehringer revise terms of diabetes drugs alliance Wednesday, 29 Oct 2014 | 8:55 AM ET

    Oct 29- Eli Lilly and Co and German drugmaker Boehringer Ingelheim said they had revised the structure of their diabetes alliance for some countries. Under the alliance signed in 2011, the companies had agreed to develop and market diabetes drugs together. Boehringer and Eli Lilly said on Wednesday that they would continue joint development and marketing of...

  • Final Glance: Pharmaceuticals companies Tuesday, 28 Oct 2014 | 6:14 PM ET

    Baxter International Inc. rose$. 47 or. 7 percent, to $70.32. Bristol-Myers Squibb Co. rose$. 67 or 1.3 percent, to $54.20. Hospira rose$. 57 or 1.1 percent, to $52.30.

  • Midday Glance: Pharmaceuticals companies Tuesday, 28 Oct 2014 | 1:25 PM ET

    Baxter International Inc. rose$. 01 or percent, to $69.86. Bristol-Myers Squibb Co. rose $1.03 or 1.9 percent, to $54.56. Hospira rose$. 15 or. 3 percent, to $51.88.

  • Early Glance: Pharmaceuticals companies Tuesday, 28 Oct 2014 | 10:31 AM ET

    Baxter International Inc. fell$. 13 or. 2 percent, to $69.72. Bristol-Myers Squibb Co. rose$. 93 or 1.7 percent, to $54.46. Hospira rose$. 23 or. 4 percent, to $51.96.

  • *Fujifilm extends gains, but fund manager says its core business uncertain. It helped drive up Seven& i Holdings Co and Aeon Co 1.0 percent and 0.6 percent, respectively. Outperforming the market was Takeda Pharmaceutical Co, which rose 2.6 percent after a U.S. judge slashed a $9 billion punitive damages award to $36.8 million against it and Eli Lilly& Co over their...

  • Final Glance: Pharmaceuticals companies Monday, 27 Oct 2014 | 6:06 PM ET

    Baxter International Inc. rose$. 02 or percent, to $69.85. Bristol-Myers Squibb Co. fell$. 10 or. 2 percent, to $53.53. Hospira fell$. 52 or 1.0 percent, to $51.73.

  • Oct 27- A U.S. judge on Monday slashed a $9 billion punitive damages award to $36.8 million against Takeda Pharmaceutical Co and Eli Lilly& Co over their Actos diabetes drug. District Judge Rebecca Doherty in Louisiana in a court filing granted a motion from the drugmakers to reduce the $9 billion in combined punitive damages awarded earlier this year.

  • Midday Glance: Pharmaceuticals companies Monday, 27 Oct 2014 | 1:17 PM ET

    Baxter International Inc. fell$. 02 or percent, to $69.81. Bristol-Myers Squibb Co. fell$. 26 or. 5 percent, to $53.37. Hospira fell$. 26 or. 5 percent, to $52.00.

  • Early Glance: Pharmaceuticals companies Monday, 27 Oct 2014 | 10:40 AM ET

    Baxter International Inc. fell$. 17 or. 2 percent, to $69.66. Bristol-Myers Squibb Co. fell$. 06 or. 1 percent, to $53.57. Hospira fell$. 27 or. 5 percent, to $51.98.

  • Final Glance: Pharmaceuticals companies Friday, 24 Oct 2014 | 6:35 PM ET

    Baxter International Inc. rose$. 73 or 1.1 percent, to $69.83. Bristol-Myers Squibb Co. rose $1.13 or 2.2 percent, to $53.63. Hospira rose$. 80 or 1.6 percent, to $52.25.

  • Midday Glance: Pharmaceuticals companies Friday, 24 Oct 2014 | 1:17 PM ET

    Baxter International Inc. rose$. 64 or. 9 percent, to $69.74. Bristol-Myers Squibb Co. rose $1.00 or 1.9 percent, to $53.50. Hospira rose$. 48 or. 9 percent, to $51.93.

  • Early Glance: Pharmaceuticals companies Friday, 24 Oct 2014 | 10:40 AM ET

    Baxter International Inc. rose$. 67 or 1.0 percent, to $69.77. Bristol-Myers Squibb Co. rose $1.28 or 2.4 percent, to $53.78. Hospira rose$. 36 or. 7 percent, to $51.81.

  • Final Glance: Pharmaceuticals companies Thursday, 23 Oct 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 73 or 1.1 percent, to $69.10. Bristol-Myers Squibb Co. rose$. 66 or 1.3 percent, to $52.50. Hospira rose $1.37 or 2.7 percent, to $51.45.